PlainRecalls
FDA Drug Critical Class I Terminated

Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ 08876. Distributed by: Amneal Pharmaceuticals, Glasgow, KY 42141. NDC 65162-687-84

Reported: December 27, 2017 Initiated: August 3, 2017 #D-0120-2018

Product Description

Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ 08876. Distributed by: Amneal Pharmaceuticals, Glasgow, KY 42141. NDC 65162-687-84

Reason for Recall

Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.

Details

Units Affected
136376 bottles
Distribution
Nationwide
Location
Brookhaven, NY

Frequently Asked Questions

What product was recalled?
Lorazepam Oral Concentrate, USP, 2 mg/mL, 30 mL bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Branchburg, NJ 08876. Distributed by: Amneal Pharmaceuticals, Glasgow, KY 42141. NDC 65162-687-84. Recalled by Amneal Pharmaceuticals of New York, LLC. Units affected: 136376 bottles.
Why was this product recalled?
Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 27, 2017. Severity: Critical. Recall number: D-0120-2018.